August 12, 2025

Exonate Initiates Phase IIb Trial of EXN407 for Diabetic Eye Disease

EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema

The Ophthalmologist

August 08, 2025

How Many Vacation Days Are Doctors Taking?

A survey by the American Medical Association shows a rise in physicians taking time off, reflecting an improvement in burnout rates.

Conexiant

August 05, 2025

Large US Study Adds to Connection Between NAION Risks and GLP-1 Drugs

Semaglutide and liraglutide showed the highest risk, while dulaglutide and exenatide were not significantly associated with NAION.

Ophthalmology Management

August 04, 2025

Keeping an Eye on Blood Sugar Status

Researchers advocate for proactive diabetes management that protects ocular health beyond retinopathy prevention

The Ophthalmologist

July 14, 2025

Dietary Nutrients and Diabetic Retinopathy

Explore the significant role of micronutrients in preventing and managing diabetic eye diseases, particularly diabetic retinopathy, as highlighted in the review by Dr. Samuel Asanad.

Retinal Physician

July 15, 2025

Aeye Health, Ford Medical Partner to Bring AI Diabetic Eye Exam Screening Solutions to Pharmacies

Ford Medical will distribute Aeye's AI screening solutions, enabling pharmacies and non-acute centers to offer an in-house, non-invasive eye exam that delivers immediate diagnostic results.

Ophthalmology Management

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

June 27, 2025

Also in the News…

The Ophthalmologist brings you the top news stories and studies of the week

The Ophthalmologist